论文部分内容阅读
目的探讨灯盏花注射液联合依那普利治疗早期糖尿病肾病临床疗效。方法 2009年1月至2011年1月诊治的符合入选标准早期糖尿病肾病患者140例,为治疗组72例,对照组68例,观察两组临床疗效。结果治疗组总有效率94.44%,对照组总有效率58.82%,两组总有效率比较P<0.05差异有统计学意义。结论灯盏花注射液联合依那普利治疗早期糖尿病肾病临床疗效显著,能够有效的改善肾脏功能,防止糖尿病肾病发展。
Objective To investigate the clinical efficacy of Erigeron Injection combined with enalapril in the treatment of early diabetic nephropathy. Methods From January 2009 to January 2011, 140 patients with early diabetic nephropathy who met the inclusion criteria were treated in the treatment group (n = 72) and control group (n = 68). Clinical efficacy was observed in both groups. Results The total effective rate of the treatment group was 94.44%, the total effective rate of the control group was 58.82%. There was significant difference between the two groups in total effective rate P <0.05. Conclusion Erigeron injection combined with enalapril treatment of early diabetic nephropathy clinically significant effect, can effectively improve renal function, prevent the development of diabetic nephropathy.